You are here

Article Text

Article menu
Download PDFPDF
Case Reports: Rare disease
Primary mucinous cell adenocarcinoma of female urethra
  1. Ravi Banthia1,2,
  2. Uday Pratap Singh1,
  3. Nayab Danish1 and
  4. Hira Lal3
  1. 1Urology and Renal Transplantation, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India
  2. 2Department of Urology, Western General Hospital, Edinburgh, UK
  3. 3Radiodiagnosis, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India
  1. Correspondence to Dr Hira Lal; hiralal2007{at}yahoo.co.in

Abstract

Primary adenocarcinoma of the female urethra is a rare entity. Its incidence increases with age with the highest rate in women aged more than 65 years. Adenocarcinoma of the urethra is more common among women than men and is associated with a relatively poor prognosis. We report a case of primary adenocarcinoma of the urethra and review the literature with emphasis on the diagnosis, management and outcome of this rare tumour.

  • Urology
  • Oncology
  • Radiology
  • Cancer intervention

https://doi.org/10.1136/bcr-2021-248507

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Twitter @RaviBanthia_uro

    • Contributors RB conceived the manuscript and this report was supervised by HL. HL provided the MR images. RB and ND prepared the manuscript. HL reviewed the manuscript. Consent was taken by RB. UPS performed the surgery. The final draft was read and approved by all the authors.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Case reports provide a valuable learning resource for the scientific community and can indicate areas of interest for future research. They should not be used in isolation to guide treatment choices or public health policy.

    • Competing interests None declared.

    • Provenance and peer review Not commissioned; externally peer reviewed.